Combined lineage tracing and scRNA‐seq reveal the activation of Sox9 + cells in renal regeneration with PGE 2 treatment
Cell Proliferation · 2024
DOI: 10.1111/cpr.13679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Shang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nankai University School of Medicine, Tianjin, China. Hauptthemen laut MEDLINE: SOX9 Transcription Factor, Dinoprostone, Regeneration, Acute Kidney Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nankai University Eye Institute, Natural Science Foundation of Tianjin Municipality, National Key Research and Development Program of China.
Abstract (Originalsprache)
Uncovering mechanisms of endogenous regeneration and repair through resident stem cell activation will allow us to develop specific therapies for injuries and diseases by targeting resident stem cell lineages. Sox9 + stem cells have been reported to play an essential role in acute kidney injury (AKI). However, a complete view of the Sox9 + lineage was not well investigated to accurately elucidate the functional end state and the choice of cell fate during tissue repair after AKI. To identify the mechanisms of fate determination of Sox9 + stem cells, we set up an AKI model with prostaglandin E2 (PGE 2 ) treatment in a Sox9 lineage tracing mouse model. Single‐cell RNA sequencing (scRNA‐seq) was performed to analyse the transcriptomic profile of the Sox9 + lineage. Our results revealed that PGE 2 could activate renal Sox9 + cells and promote the differentiation of Sox9 + cells into renal proximal tubular epithelial cells and inhibit the development of fibrosis. Furthermore, single‐cell transcriptome analysis demonstrated that PGE 2 could regulate the restoration of lipid metabolism homeostasis in proximal tubular epithelial cells by participating in communication with different cell types. Our results highlight the prospects for the activation of endogenous renal Sox9 + stem cells with PGE 2 for the regenerative therapy of AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nankai University School of Medicine, Tianjin, China.
- The Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, Tianjin, China.
- Department of Ophthalmology, The Third Medical Center of Chinese PLA General Hospital, Beijing, China.
- National Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
- MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
- Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
ORCID-Profile: Zongjin Li
Förderung
- Nankai University Eye Institute
- Natural Science Foundation of Tianjin Municipality
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Chen, S., Liu, Y., Chen, X., Tao, H., Piao, Y., Huang, H., Han, Z., Han, Z. C., Chen, X. M., & Li, Z. (2024). Combined lineage tracing and scRNA‐seq reveal the activation of Sox9 + cells in renal regeneration with PGE 2 treatment. Cell Proliferation. https://doi.org/10.1111/cpr.13679
Vancouver
Chen S, Liu Y, Chen X, Tao H, Piao Y, Huang H, et al. Combined lineage tracing and scRNA‐seq reveal the activation of Sox9 + cells in renal regeneration with PGE 2 treatment. Cell Proliferation. 2024. doi:10.1111/cpr.13679
BibTeX
@article{Chen2024,
author = {Chen, Shang and Liu, Yue and Chen, Xiaoniao and Tao, Hongyan and Piao, Yongjun and Huang, Haoyan and Han, Zhibo and Han, Zhong-Chao and Chen, Xiang-Mei and Li, Zongjin},
title = {Combined lineage tracing and scRNA‐seq reveal the activation of Sox9 + cells in renal regeneration with PGE 2 treatment},
journal = {Cell Proliferation},
year = {2024},
doi = {10.1111/cpr.13679}
}
EUVIMED